CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brimacombe, J.
Right arrow Articles by Keller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brimacombe, J.
Right arrow Articles by Keller, C.
Canadian Journal of Anesthesia 51:254-257 (2004)
© Canadian Anesthesiologists' Society, 2004

Cardiothoracic Anesthesia, Respiration and Airway

Supplementary cleaning does not remove protein deposits from re-usable laryngeal mask devices

[Le nettoyage supplémentaire n’enlève pas les dépôts de protéine sur les masques laryngés réutilisables]

Joseph Brimacombe, MB CHB FRCA MD*, Tisha Stone, MB BS* and Christian Keller, MD{dagger}

* From the Departments of Anaesthesia and Intensive Care, Cairns Base Hospital, Cairns, Australia; and
{dagger} The Leopold-Franzens University, Innsbruck, Austria.

Address correspondence to: Prof. J. Brimacombe, Department of Anaesthesia and Intensive Care, Cairns Base Hospital, The Esplanade, Cairns 4870, Australia. E-mail: jbrimaco{at}bigpond.net.au


    Abstract
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Purpose: To test the hypothesis that supplementary cleaning facilitates removal of protein deposits from the laryngeal mask airway (LMA).

Methods: Twenty previously used ClassicTM and FlexibleTM LMAs were hand washed, machine washed, dried, autoclaved and then randomly allocated into four groups for supplementary cleaning. In Group A, the dorsal surface was immersed in water and the surface scrubbed with a high-speed rotating brush. In Group B, the dorsal surface was immersed in a plaque removing solution. In Group C, the dorsal surface was immersed in a protein removing solution. In Group D (controls), the dorsal surface was immersed in water. Before and after supplementary cleaning the LMAs were immersed in a protein staining solution, rinsed and a high-resolution digital image taken of the dorsal surface. The location and severity of staining were scored by two observers blinded to group assignment.

Results: Staining was similar before and after supplementary cleaning for all groups. Mild, moderate and severe staining occurred in 31%, 7% and 2% of zones respectively; 60% were unstained. Staining was less common on the cuff than on the backplate and distal tube (both: P < 0.00001). Staining was less common on the backplate than on the distal tube (P = 0.001). Staining was always present on the mid-portion of the backplate or distal tube.

Conclusion: Supplementary cleaning using a rotating brush, plaque or protein removing solution does not facilitate removal of protein deposits from re-usable LMAs; however, the infectious risk associated with the protein deposits remains to be determined.


    Introduction
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
BOVINE spongiform encephalopathy appeared in British cattle in 1986, and was recognized in humans in 1996 having crossed the species barrier.1 It is caused by an infectious prion protein2 that is highly resistant to decontamination by routine cleaning and autoclaving procedures.1,3 Though little is known about the risk of cross-infection from re-usable surgical and anesthesia equipment, it has been suggested that all surgical patients are screened for prion disease, or all equipment made disposable;4,5 however, the economic consequences of these options are considerable. One of the most common re-usable items of anesthesia equipment is the laryngeal mask airway (LMA). Miller et al.4 showed that: 1) hand washing with detergent and autoclaving does not remove all protein contamination from re-usable LMA devices; and 2) most staining occurs on the dorsal surface of the cuff portion. We test the hypothesis that supplementary cleaning facilitates removal of protein deposits from the LMA. We also determine the distribution of protein deposits on the dorsal surface of the cuff.


    Methods
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Twenty previously used ClassicTM and FlexibleTM LMAs (Laryngeal Mask Company, Henley-on-Thames, UK) were tested at the end of a working day (greater than ten uses; pre-use check tests passed).6 Each LMA was cleaned and sterilized as follows: 1) immersion in a mild enzymatic solution (Enzyme Rapid, 3M, Pymble, Australia) for three minutes; 2) washing the external surfaces with a cloth for at least one minute or until all visible material was removed; 3) washing the airway tube with a soft bristled brush or until all visible material was removed; 4) placing the LMA in an automatic washer for 14 min which included warm washing at 55°C with a disinfectant and hot washing at 85°C; 5) placing in a dryer for 30 min at 75°C; and 6) autoclaving at 134°C for four minutes at 206 kPa.

The LMAs were randomly allocated (by opening an opaque envelope) into four equal-sized groups for supplementary cleaning. In Group A, the dorsal surface was immersed in water and the surface scrubbed with a high-speed, 1-cm wide rotating brush for two minutes (3D pulsating toothbrush 4729, Braun, Germany). In Group B, the dorsal surface was immersed in a plaque removing solution for 30 min (Plax Fresh Mouthwash, Colgate Oral Care, Sydney, Australia). In Group C, the dorsal surface was immersed in a protein removing solution for five hours (subtilisin 0.01 mg•mL-1 AMO Complete Protein Remover, Advanced Medical Optics, Sydney, Australia). In Group D (controls), the dorsal surface was immersed in water for five hours. Before and after supplementary cleaning the LMAs were immersed for 30 min in a protein staining solution (1.2% erythrosin B),7 rinsed in water at 20°C for one minute and a high resolution digital image (3.3 megapixels) taken of the dorsal surface. The images were analyzed by dividing the dorsal surface into 20 zones (Figure 1Go) and scoring the severity of staining in each zone according to the percentage of area stained: 0 (nil), 1 (mild, <= 10%), 2 (moderate, > 10%–50%) and 3 (severe, > 50%). The overall staining score was determined by adding the staining scores from the 20 zones (maximum score 60). The images were analyzed by two observers blinded to the timing of the staining and the type of supplementary cleaning, and the average taken. Another three previously used LMAs (history as above) were collected, stained, cleaned with the protein removing solution, restained and photographed as above, but were also photographed just before the second staining. Sample size was selected for a type I error of 0.05 and a power of 0.85 with four groups and was based on a pilot study with four LMAs with an effect size of 0.644. Statistical analysis was with Chi squared test.



View larger version (107K):
[in this window]
[in a new window]
 
FIGURE 1 Zones on the dorsal portion of the cuff.

 

    Results
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
There were no differences in scoring among observers. Staining was similar before and after supplementary cleaning for all groups (Table IGo). The mean (range) overall staining score was 10 (3–27). Mild, moderate and severe staining occurred in 31%, 7% and 2% of zones respectively; 60% of zones were unstained. Staining was less common on the cuff than the backplate and distal tube (both: P < 0.00001; Table IIGo). Staining was less common on the backplate than the distal tube (P = 0.001; Table IIGo). Staining was more common on the mid-portion of the backplate (P = 0.002) and distal tube (P = 0.003) than any other zone (Table IIGo). All devices had staining on the mid-portion of the backplate or distal tube. On three devices linear abrasions showed up as areas of severe staining (Figure 2Go). The three additional LMAs cleaned in the protein removing solution showed that supplementary cleaning removed most of the first stain (median score 16 vs 4), but this reappeared with the same distribution and severity after the second stain (median score 16).


View this table:
[in this window]
[in a new window]
 
TABLE I Overall staining score before and after supplementary cleaning
 

View this table:
[in this window]
[in a new window]
 
TABLE II Severity of staining by location
 


View larger version (130K):
[in this window]
[in a new window]
 
FIGURE 2 Typical staining of the mid-portion of the backplate and distal cuff (short arrows). There is also a stained abrasion (long arrow).

 

    Discussion
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We found that supplementary cleaning using a rotating brush, plaque or protein removing solution does not facilitate removal of protein deposits from the re-usable LMA. This suggests that proteins, once attached, are highly adherent to the surface of the LMA. Options for increasing the efficacy of protein removal include: 1) increasing the abrasiveness, speed and/or duration of brushing; 2) using different and/or stronger solutions for a greater duration; and 3) increasing the temperature and/or duration of autoclaving. However, all these techniques run the risk of damaging the device. Another option might be to modify the sequence of cleaning.

We found that protein staining was more common on the backplate and distal tube than the cuff. This may be related to their surfaces being more irregular at a microscopic level or due to increased exposure to protein contamination. Interestingly, we found that staining occurred most commonly on the mid-portion of the backplate and distal tube. This is the surface that is pressed most firmly into the mucosa during insertion. We speculate that transient high mucosal pressures combined with shearing forces during insertion increase the level of protein contamination in this area. The presence of severe staining on three linear abrasions indicates the ease with which protein can collect on irregular surfaces.

We found protein deposits on all LMAs before supplementary cleaning confirming Miller et al.’s 4 finding that conventional cleaning and autoclaving does not remove all protein deposits; however, our level of contamination may have been lower since moderate and severe staining occurred in less than 10% of zones, whereas Miller et al.4 graded 45% of LMAs as moderately or heavily stained. Our finding that supplementary cleaning removed most of the first stain, but not the underlying protein, as indicated by its reappearance with the second stain, suggests that the first stain did not protect the protein from removal.

The risk of prion disease transmission from re-usable LMAs is unknown. Although the frequency of prion disease is around one per million3 and the number of LMA uses is around 20 million per annum, an accurate estimate of risk cannot be determined since there are no data about the frequency of LMA contamination from an infected patient, no data about the infective dose, and no data about the amount of contaminant removed or denatured with each use/cleaning/autoclave cycle. There are no reports of prion or other infections from re-usable LMAs, but prion transmission via blood8 and oral inoculation9 has been reported in animal models.

We conclude that the supplementary cleaning using a rotating brush, plaque or protein removing solution does not facilitate removal of protein deposits from re-usable LMAs. The mid-portion of the backplate and distal tube is the most heavily stained area on the dorsal surface of the cuff. The infectious risk associated with such protein deposits remains to be determined.


    Footnotes
 
Disclosure: This project was supported solely by departmental resources.

Accepted for publication July 8, 2003. Revision accepted November 28, 2003.


    References
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
1 Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jacob disease in the UK. Lancet 1996; 347: 921–5.[Medline]

2 Haltia M. Human prion diseases. Ann Med 2000; 32: 493–500.[Medline]

3 Hilton DA. VCJD–predicting the future? Neuropathol Appl Neurobiol 2000; 26: 405–7.[Medline]

4 Miller DM, Youkhana I, Karunaratne WU, Pearce A. Presence of protein deposits on ‘cleaned’ re-usable anaesthetic equipment. Anaesthesia 2001; 56: 1069–72.[Medline]

5 Smith G. Variant CJD; what you need to know at present. The Royal College of Anaesthetists Bulletin 2001; 7: 302–4.

6 Verghese C. LMA-ClassicTM, LMA-FlexibleTM, LMA-UniqueTM. Instruction Manual. Henley-on-Thames: The Laryngeal Mask Company Ltd; 1999.

7 Leknes KN, Lie T. Erythrosin staining in clinical disclosure of plaque. Quintessence Int 1988; 19: 199–204.[Medline]

8 Hunter N, Foster J, Chong M, et al. Transmission of prion disease by blood transfusion. J Gen Virol 2002; 83: 2897–905.[Abstract/Free Full Text]

9 Bartz JC, Kincaid AE, Bessen RA. Rapid prion neuroinvasion following tongue infection. J Virol 2003; 77: 583–91.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. Lange, T. Smul, P. Zimmermann, R. Kohlenberger, N. Roewer, and F. Kehl
The Effectiveness and Patient Comfort of the Novel Streamlined Pharynx Airway Liner (SLIPA(R)) Compared with the Conventional Laryngeal Mask Airway in Ophthalmic Surgery
Anesth. Analg., February 1, 2007; 104(2): 431 - 434.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brimacombe, J.
Right arrow Articles by Keller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brimacombe, J.
Right arrow Articles by Keller, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS